Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS ClinicalTrials.gov record update

An Exploratory, Open-label, Multicenter Study to Evaluate the Safety and Efficacy of Anti-minor Histocompatibility Complex (MiHA) Donor T-lymphocytes Expanded ex Vivo, in Patients With a Hematologic Malignancy, With Molecular or Clinical Relapse After Hematopoietic Stem Cell Transplantation From a Matched Donor

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source
ClinicalTrials.gov
Source record ID
NCT03091933
Title field or adapter rule
protocolSection.identificationModule.officialTitle
Ingested At
2026-04-28T10:36:44.374626+00:00
Published At
2017-12-06T00:00:00+00:00
Record Updated At
2017-12-06
Timestamp Basis
source retrieval time was not retained by the feed adapter
Date limitation
source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions
["Hematologic Cancer", "Relapse Leukemia", "Relapsed Adult ALL", "Relapsed Adult AML", "Relapsed CLL", "Relapsed Non Hodgkin Lymphoma", "Relapsed Hodgkin\u0027s Lymphoma", "Relapsed Myelodysplastic Syndromes", "Relapsed Multiple Myeloma"]
protocolSection.statusModule.lastUpdatePostDateStruct.date
"2017-12-06"
protocolSection.identificationModule.nctId
"NCT03091933"
protocolSection.identificationModule.officialTitle
"An Exploratory, Open-label, Multicenter Study to Evaluate the Safety and Efficacy of Anti-minor Histocompatibility Complex (MiHA) Donor T-lymphocytes Expanded ex Vivo, in Patients With a Hematologic Malignancy, With Molecular or Clinical Relapse After Hematopoietic Stem Cell Transplantation From a Matched Donor"
protocolSection.statusModule.overallStatus
"UNKNOWN"
protocolSection.designModule.phases
["PHASE1", "PHASE2"]
protocolSection.statusModule.resultsFirstPostDateStruct.date
""

Study condition terms

  • Hematologic Cancer (protocolSection.conditionsModule.conditions)
  • Relapse Leukemia (protocolSection.conditionsModule.conditions)
  • Relapsed Adult ALL (protocolSection.conditionsModule.conditions)
  • Relapsed Adult AML (protocolSection.conditionsModule.conditions)
  • Relapsed CLL (protocolSection.conditionsModule.conditions)
  • Relapsed Non Hodgkin Lymphoma (protocolSection.conditionsModule.conditions)
  • Relapsed Hodgkin's Lymphoma (protocolSection.conditionsModule.conditions)
  • Relapsed Myelodysplastic Syndromes (protocolSection.conditionsModule.conditions)
  • Relapsed Multiple Myeloma (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.